Zydus Cadila’s Covid Vaccine For Kids Above 12 Likely To Get Approval This Week

India’s drug regulator Drugs Controller General of India (DCGI) will consider giving an emergency use nod to Covid-19 vaccines developed by Zydus Cadila for children above 12 years.

As per the official reports, the vaccine has been tested on adults as well as children above 12 years of age and if the regulatory committee is satisfied with the data, it may be given approval for emergency use.

The report further added that the regulator’s subject expert committee (SEC) will examine data submitted by Cadila and if the SEC finds the phase 3 data of the vaccine company satisfactory, the emergency use authorisation for the vaccine can be granted this week itself.

The report then added that if the approval is given then the supply of the vaccine is expected to start by August- September. 

Earlier Dr NK Arora, Chairperson of the Covid-19 Working Group of the National Technical Advisory Group on Immunization (NTAGI) stated that the Zydus Cadila’s vaccine for the age group of 12-18 years is expected to be available by September end.

Image Source – Google